ISSN : 2663-2187

Stability-indicating Reverse phase-HPLC Method development and Method Validation for Quantitative determination of Degradation products in Molnupiravir

Main Article Content

Varada Soujanya and Revu Baby Nalanda
ยป doi: 10.33472/AFJBS.6.Si2.2024.126-145

Abstract

Molnupiravir is an antiviral medication shown to be broad spectrum activity against RNA viruses, and potentially treating the COVID-19. In this study, the HPLC method for the quantification of degradation impurities (Trihydroxy and Isobutryryl Oxide Impurities) were developed and validated for Molnupiravir in Tablet dosage form

Article Details